EXTL1 Activators
EXTL1 activators are chemicals that indirectly influence the activity of EXTL1 by modulating the glycosaminoglycan biosynthesis pathway. These activators do not bind directly to EXTL1 but affect its activity by altering substrate availability, chain initiation, or the structural maturation of glycosaminoglycans.
The glycosaminoglycan biosynthesis pathway involves several stages, including the initiation of chain synthesis, elongation, and modification processes like sulfation and acetylation. Chemicals such as glucosamine and galactose serve as substrates for the synthesis of these complex polysaccharides, enhancing the overall pathway efficiency, and indirectly influencing the activity of enzymes like EXTL1. UDP-Glucuronic acid and Acetyl-CoA are critical for the addition and modification of monosaccharide units in glycosaminoglycan chains.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D-Glucosamine | 3416-24-8 | sc-278917A sc-278917 | 1 g 10 g | $201.00 $779.00 | ||
Glucosamine is an amino sugar that serves as a substrate for the synthesis of glycosaminoglycans. By increasing the availability of this substrate, it can indirectly enhance the activity of glycosyltransferases like EXTL1. | ||||||
D-Galactose | 59-23-4 | sc-202564 | 100 g | $288.00 | 4 | |
Galactose is a monosaccharide that is a crucial building block in the synthesis of glycosaminoglycans. Its presence can indirectly support the enzymatic activity of EXTL1 in glycosaminoglycan chain elongation. | ||||||
Uridine 5′-diphosphoglucose disodium salt from Saccharomyces cerevisiae | 28053-08-9 | sc-222402 sc-222402A | 10 mg 25 mg | $27.00 $34.00 | ||
UDP-Glucuronic acid is a key precursor in the synthesis of glycosaminoglycans. It can influence EXTL1 indirectly by being a substrate for the formation of heparan sulfate chains. | ||||||
Acetyl coenzyme A trisodium salt | 102029-73-2 | sc-210745 sc-210745A sc-210745B | 1 mg 5 mg 1 g | $47.00 $92.00 $5826.00 | 3 | |
Acetyl-CoA is involved in the acetylation of amino sugars, a process critical for glycosaminoglycan biosynthesis. This can indirectly impact EXTL1 function by modifying substrate availability. | ||||||
L-Ascorbic acid, free acid | 50-81-7 | sc-202686 | 100 g | $46.00 | 5 | |
Ascorbic acid, or vitamin C, is known to enhance the synthesis of glycosaminoglycans, thereby potentially influencing EXTL1 activity. | ||||||
4-Methylumbelliferyl-β-D-xylopyranoside | 6734-33-4 | sc-220964 sc-220964A | 25 mg 100 mg | $71.00 $233.00 | ||
β-D-xyloside can initiate the synthesis of glycosaminoglycan chains independently of the core protein, potentially modifying EXTL1 activity. | ||||||
Manganese | 7439-96-5 | sc-250292 | 100 g | $270.00 | ||
Manganese is a cofactor for several enzymes in the glycosaminoglycan biosynthesis pathway, potentially affecting EXTL1 activity. | ||||||
Sodium chlorate | 7775-09-9 | sc-212938 | 100 g | $59.00 | 1 | |
Sodium chlorate inhibits sulfation in glycosaminoglycans, which could indirectly alter EXTL1 activity by changing the substrate characteristics. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Hydroxychloroquine can modulate the synthesis and structure of glycosaminoglycans, thus potentially influencing EXTL1 activity. | ||||||